Author

K. Fujiyama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:mechanistic / dynamical model· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Du· 1 shared H. Guo· 1 shared H. Kajiura· 1 shared H. Osada· 1 shared K. Ikuta· 1 shared K. Kinugasa· 1 shared K. L. Mayer· 1 shared K. Watanabe· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Du

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Impact of glycoengineering and immunogenicity on the anti-cancer activity of a plant-made lectin-Fc fusion protein

M. Dent, K. L. Mayer, N. Verjan Garcia, H. Guo, H. Kajiura, K. Fujiyama, N. Matoba

This study shows that glycoengineering AvFc to remove plant glycans enhances its anti-cancer activity by improving Fc receptor binding and ADCC, while being unaffected by anti-drug antibodies.

bioRxiv · May 31, 2022 · PreprintCancer Biology

Molecular basis for two stereoselective Diels-Alderases that produce decalin skeletons

K. Fujiyama, N. Kato, S. Re, K. Kinugasa, K. Watanabe, R. Takita, T. Nogawa, T. Hino, H. Osada, Y. Sugita, S. Takahashi, S. Nagano

This study determines the molecular mechanisms of two Diels-Alderases that produce enantiomeric decalin scaffolds through structural and computational analyses.

bioRxiv · Feb 1, 2021Biochemistry

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B

T. Matsumura, S. Amatsu, R. Misaki, M. Yutani, A. Du, T. Kohda, K. Fujiyama, K. Ikuta, Y. Fujinaga

This study develops fully human monoclonal antibodies against BoNT/B that show potent neutralization activity and broad subtype coverage, with therapeutic and prophylactic effects in mice.

bioRxiv · Dec 18, 2019Microbiology